Immersive Virtual Reality During Robot-assisted Walking.
The Use of Immersive Virtual Reality During Robot-assisted Walking in Healthy Adults - Effect of Changing the Optic Flow Speed in Two Different Virtual Environments on Active Participation During Robot-assisted Walking.
1 other identifier
interventional
28
1 country
1
Brief Summary
The aim of this study is to investigate the effect of manipulating the optic flow (OF) speed in 2 different virtual environments (VE) on active participation in healthy participants during virtual reality (VR) - enhanced robot-assisted gait(RAG). The second aim is to investigate the effect of two different VEs on active participation during RAG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2018
CompletedFirst Posted
Study publicly available on registry
March 8, 2018
CompletedStudy Start
First participant enrolled
September 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2019
CompletedApril 24, 2019
April 1, 2019
7 months
February 19, 2018
April 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Muscle activity (EMG)
Muscle activity will be measured continuously during the 21 minutes of testing. Average muscle activity (%MVIC) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Interaction torques left hip
Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Interaction torques left knee
Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Interaction torques right hip
Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Interaction torques right knee
Interaction torques will be measured continuously during the 21 minutes of testing. Average interaction torques (Nm) between participant and device will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Range of motion left hip
Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Range of motion left knee
Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Range of motion right hip
Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Range of motion right knee
Range of motion will be measured continuously during the 21 minutes of testing. Average range of motion (°) will be measured at different time frames. Offline calculation (e.g. averages) will be performed afterwards.
Every minute of the 21-minute session.
Study Arms (2)
Stimulus rich VE
EXPERIMENTALParticipants will be tested during 1 RAG session in the Lokomat. Participants in the experimental group will walk in a stimulus rich VE such as walking in a park.
Stimulus poor VE
ACTIVE COMPARATORParticipants will be tested during 1 RAG session in the Lokomat. Participants in the control group will walk in a stimulus poor VE, such as walking through an endless hallway.
Interventions
Participants will walk in the Lokomat with the VR for 21 minutes. After every 7 minutes, the speed of the OF will change (2 times the comfortable walking speed, equally to the comfortable walking speed, and 0.5 times the comfortable walking speed).
Participants will walk in the Lokomat with the VR for 21 minutes. After every 7 minutes, the speed of the OF will change (2 times the comfortable walking speed, equally to the comfortable walking speed, and 0.5 times the comfortable walking speed).
Eligibility Criteria
You may qualify if:
- Healthy persons ≥ 55 years of age,
- Normal or corrected-to-normal vision with glasses or contact lenses,
- No locomotion impairments,
- A maximal body weight of 135 kg,
- A maximal body height of 200 cm
You may not qualify if:
- Skin lesions that cannot be protected appropriately,
- Significant lower extremity injuries during the last two years that might affect their gait,
- Any type of vestibular/visual deficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rehabilitation center TrainM
Antwerp, 2018, Belgium
Study Officials
- STUDY CHAIR
Eric Kerckhofs, Prof. Ph.D
Vrije Universiteit Brussel
- STUDY DIRECTOR
Eva Swinnen, Prof. Ph.D
Vrije Universiteit Brussel
- PRINCIPAL INVESTIGATOR
Emma De Keersmaecker, Ph.D student
Vrije Universiteit Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Researcher
Study Record Dates
First Submitted
February 19, 2018
First Posted
March 8, 2018
Study Start
September 12, 2018
Primary Completion
April 13, 2019
Study Completion
April 13, 2019
Last Updated
April 24, 2019
Record last verified: 2019-04